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Background: 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography (18F-FDG-PET) is applied in the clinic
for infection assessment and is under consideration for investigating the inflammatory/immune response in
lymphoid tissue in animal models of viral infection. Assessing changes in 18F-FDG uptake of lymph nodes (LNs),
primary lymphoid tissues targeted during viral infection, requires suitable methods for image analysis. Similar to
tumor evaluation, reliable quantitation of the LN function via multiple 18F-FDG-PET sessions will depend how the
volume of interest is defined. Volume of interest definition has a direct effect on statistical outcome. The current
study objective is to compare for the first time agreement between conventional and modified VOI metrics to
determine which method(s) provide(s) reproducible standardized uptake values (SUVs) for 18F-FDG uptake in the
LN of rhesus macaques.
Methods: Multiple 18F-FDG-PET images of LNs in macaques were acquired prior to and after monkeypox virus
intravenous inoculation. We compared five image analysis approaches, SUVmax, SUVmean, SUVthreshold, modified
SUVthreshold, and SUVfixed volume, to investigate the impact of these approaches on quantification of the changes in
LN metabolic activity denoting the immune response during viral infection progression.
Results: The lowest data repeatability was observed with SUVmax. The best correspondence was between
SUVfixed volume and conventional and modified SUVthreshold. A statistically significant difference in the LN
18F-FDG uptake
between surviving and moribund animals was shown using modified SUVthreshold and SUVfixed volume (adjusted
p = 0.0037 and p = 0.0001, respectively).
Conclusions: Quantification of the LN 18F-FDG uptake is highly sensitive to the method applied for PET image analysis.
SUVfixed volume and modified SUVthreshold demonstrate better reproducibility for SUV estimates than SUVmax, SUVmean,
and SUVthreshold. SUVfixed volume and modified SUVthreshold are capable of distinguishing between groups with different
disease outcomes. Therefore, these methods are the preferred approaches for evaluating the LN function during viral
infection by 18F-FDG-PET. Validation of multiple approaches is necessary to choose a suitable method to monitor
changes in LN metabolic activity during progression of viral infection.
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Assessment of cell glucose metabolism by 2-deoxy-2-
[18F]fluoro-D-glucose (18F-FDG) and positron emission
tomography (PET) is a powerful supplement to conven-
tional studies of viral infection in animal models to
characterize disease progression and evaluate the efficacy
of potential treatments [1,2]. Lymphadenopathy is one of
the predominant clinical signs of monkeypox virus infec-
tion in nonhuman primates (NHPs) and humans. There-
fore, a reasonable method to monitor the evolving lymph
node (LN) immune response is assessment of LN meta-
bolic activity using standardized uptake value (SUV) as a
simple semiquantitative measure of 18F-FDG uptake [3,4].
Similar to the methodological issues associated with the
analysis of 18F-FDG-PET images in oncology [5], comput-
ing the SUVs and reliably evaluating the LN immune
response to viral infection will depend on an exact and re-
producible definition of the volume of interest (VOI). VOI
definition for PET image quantitation is still an open re-
search area, and users are applying the most reliable and
reproducible techniques suitable for analysis of different
types of disease (e.g., tumors, inflammatory conditions).
Although the VOI definition is not the only factor that
can affect the reproducibility of SUV estimates in the LN
[5-7], the type and size of a VOI may greatly contribute to
the variability of such measurements. Such variation has
been previously demonstrated with tumor quantitation
using 18F-FDG-PET imaging [7,8].
A variety of methods have been proposed to define
tumor VOI, but no reference standard has been accepted.
Commonly used approaches for quantitative analysis of
18F-FDG-PET images include the following: 1) measuring
the value of the voxel with the highest activity within the
tumor (SUVmax) [9,10], 2) averaging the SUVs from the
voxels inside the whole tumor defined by freehand outline
of tumor boundaries (SUVmean) [11-13], 3) averaging the
voxels with the SUVs greater than a certain percentage
of SUVmax using thresholding techniques (SUVthreshold)
[7,14,15], or 4) using fixed volume (SUVfixed volume) de-
fined as the average SUV within a fixed-size VOI centered
over a region with high metabolic activity without con-
forming to the precise tumor outline. A similar concept of
SUVfixed volume has been used by Boellaard et al. and was
called SUVpeak [6].
These VOI metrics are rather general and, as such, are
not optimized to detect reproducible changes in 18F-FDG
uptake (as measured by SUVs) during viral infection
progression in a small target organ (LN). In particular,
18F-FDG uptake during early viral infection is difficult to
measure as normal or near normal LNs have low glyco-
lytic activity comparable to background. The lack of data
on the agreement between varied methods to provide re-
producible SUV estimates of the metabolic activity of LN
has prompted us to develop new methods for VOImetrics. We evaluated new methods, SUVfixed volume and
modified SUVthreshold (mSUVthreshold), against conven-
tional (SUVmax, SUVmean, SUVthreshold) metrics. Here, we
report the statistical reliability of each of these methods
on quantitative assessment of 18F-FDG uptake changes in
axillary LNs of rhesus macaques (Macaca mulatta) fol-
lowing a monkeypox virus intravenous challenge. To test
interscan reproducibility, data from three baseline com-
puted tomography (CT) and PET scans prior to monkey-
pox virus inoculation were used to measure LN volumes
and SUVmax, SUVmean, SUVthreshold, SUVfixed volume, and
mSUVthreshold in these animals.
Methods
Animals were housed in a facility accredited by the Asso-
ciation for Assessment and Accreditation of Laboratory
Animal Care International. All experimental procedures
were approved by the National Institute of Allergy and In-
fectious Diseases, Division of Intramural Research, Animal
Care and Use Committee and were in compliance with
the Animal Welfare Act regulations, Public Health Service
policy, and the Guide for the Care and Use of Laboratory
Animals recommendations.
Subjects
Six male rhesus macaques housed in biosafety level 3
containment, weighing 3 to 4 kg, were infected intraven-
ously with 5 × 107 plaque forming units of monkeypox
virus (MPXV Zaire 79 strain [V-79-I-005]) (for virus
preparation and inoculation procedures, see Additional
file 1). Three animals were treated intravenously with
cidofovir (5 mg/ml/kg in Dulbecco’s modified Eagle’s
medium; Gilead Sciences, Foster City, CA, USA) that
has been shown to protect against monkeypox virus in-
fection. The antiviral agent, cidofovir, was administered
on day −1 prior to monkeypox virus challenge and on
days +1, +3, +5, +7, +10, and +13 after challenge. NHPs
received 25 mg/kg of probenecid by gavage 1 h before
cidofovir injection to prevent cidofovir nephrotoxicity.
Three animals comprised the untreated control group.
Data acquisition
Up to nine imaging sessions were conducted in each of
the six animals following the procedures described pre-
viously [1]. Briefly, imaging data were acquired in ani-
mals anesthetized with isoflurane (2% to 2.5%) (Piramal
Critical Care, Orchard Park, NY, USA) using a micro-
PET scanner Focus-220 (Siemens AG, Malvern, PA,
USA). This scanner has a bore size of 22 cm with an
axial field-of-view of 7.6 cm and a transverse field-of-
view of 19 cm [16]. Multiple static PET scans were
initiated 1 h after the intravenous 18F-FDG injection
(9.25 MBq/kg) and continued for 10 min for each of two
bed positions on different days over 1.5 months. Three
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lation (days −20, −15, and −5) and up to six scans were
conducted postinoculation (days +1 or +2, +3 or +4, +7
or +8, +10, +16, and +21). The scans were conducted in
the morning; the animals were fasted overnight for 12 h
prior to the scanning session. The blood glucose concen-
trations were measured prior to the 18F-FDG injection be-
fore each scanning sessions. PET images were acquired in
three-dimensional (3D) mode and reconstructed itera-
tively using 3D-ordered subsets expectation maximization
algorithm with two iterations and nine subsets followed
by 18 iterations of maximum a posteriori reconstruction
[17]. Maximum a posteriori parameters were adjusted to
provide a uniform spatial resolution of 1.8 mm (FWHM=
1.8 mm) in all three directions. Methods for scatter, decay,
random, and attenuation correction were applied during
the process of PET image reconstruction.
CT images were acquired with a CereTom® (NeuroLogica
Corp., Danvers, MA, USA) 8-slice mobile head-and-neck
CT scanner that was installed in close proximity to the
microPET scanner. The CereTom® CT scanner provided
190 slices with 0.49 × 0.49 mm in-plane resolution and
1.25-mm slice thickness that were acquired at 120 kVp
and 5 mA. CT scans were taken either immediatelyFigure 1 Definition of ROIs used for 18F-FDG uptake quantitation in t
obtained on day 3 (b) and day 8 (a,c) postinoculation of monkeypox virus
(iv) (see “Methods” for details). (b) An example of inclusion of the voxels (c
voxels (black) within the LN when SUVthreshold metrics was applied to PET i
placement within the LN edges. Images represent a middle slice of a LN in
axis dimensions. The intersection of the two axes identifies a LN center.before or after PET imaging to ensure consistent animal
position and fusion of the PET and CT scans for data
analysis. Incorporating the use of the same table for
both scanners eliminated the need for animal reposi-
tioning. To restrict animal motion, the animal was se-
cured by anchoring the limbs and by controlling the
level of anesthesia. CT scans were used for attenuation
correction and coregistration with PET images to define
anatomical localization of the LNs of interest. In addition,
CT images were used to obtain the LN volume applied for
SUVmean computation to determine interscan data repro-
ducibility prior to viral challenge.
Image analysis
Data analysis was performed using MIM workstation
software version 5.2.2 (MIM Software Inc., Cleveland,
OH, USA). The largest LN in the axillary fossa was
chosen for analysis. This LN usually is positioned close
to the body surface and easy to identify. VOIs were first
specified on CT images coregistered with PET images.
The volume of a whole LN was delineated by manually
drawing the peripheral boundary on each of the slices
where it appeared (Figure 1a (i)). SUVs from all the voxels
inside this volume were averaged to calculate SUVmean.he axillary LN. CT, PET, and fused CT/PET images of the same LN
. (a) SUVmean (i), SUVthreshold (ii), mSUVthreshold (iii), and SUVfixed volume
hartreuse) from surrounding tissue with higher SUVs compared to the
mage. (c) Delineation of a LN center and dimensions for VOIs
sagittal, transaxial, and coronal views showing the long and a short
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identified by the MIM program was recorded as SUVmax.
To compute the SUVthreshold, a ‘threshold’ option in
MIM was selected to place a sphere around the whole LN
(Figure 1a (ii)). The tool averaged the voxels inside the
sphere above a specified threshold that was set at 50% of
the maximal voxel value. As the LN metabolic activity was
often below that of surrounding tissue at baseline
(Additional file 2) and during early infection (day 3/4,
Additional files 2 and 3, Figure 1b), we also used a modi-
fied SUVthreshold (mSUVthreshold) method to exclude the
voxels outside the LN. mSUVthreshold was calculated by
averaging all the voxels with SUVs above 50% of the max-
imal value within a sphere inside the LN edges (Figure 1a
(iii)). The diameter of a sphere was chosen based on the
smallest LN axis defined on CT images. First, to specify
the smallest axis, the CT images in 3D view were exam-
ined to identify the edges and the center of a LN
(Figure 1c). When the approximate center of a LN was lo-
cated, two perpendicular lines were drawn on LN slices in
transaxial, coronal, and sagittal views following the largest
and the smallest LN axis on each view (Figure 1c). When
the sphere diameter was specified, the sphere was placed
strictly within the edges of the LN (Figure 1a (iii)).
We also applied a fixed dimension method,
SUVfixed volume, by creating a template of three identi-
cal small spheres (0.2 cm diameter, total of 21 full
voxels in all three spheres), placed contiguously within the
longest axis of the LN. The sphere diameter was chosen
based on the smallest LN axis (range 0.25 to 0.39 cm)
among all animals determined on baseline CT images.
The three spheres were transferred to each new data set
by determining the center of the LN (defined by the inter-
section of axes in 3D view, Figure 1c), placing the middle
sphere in the LN center and the other two spheres adja-
cent to the first one along the long axis of a LN in transax-
ial view. By using three small spherical VOIs, we adjusted
the VOI location to the shape of the LN of each subject.
Although the size and shape of the LNs differed, the VOI
covered similar locations in the middle of each LN. The
SUVfixed volume was computed by averaging the SUVs from
21 voxels covered by three spheres.
For SUV calculation, the radioactivity concentration from
the VOI on the PET image was divided by the injected
dose and normalized to the body weight of the animal and
radioactive decay for the time point of 18F-FDG injection
SUV ¼ decay corrected radioactivity concentration
MBq=mlð Þ  injected dose MBqð Þ  body weight gð Þ
Statistical analysis
The correlation between the volume measurement on
pre-inoculation CT scans 1 and 2, 1 and 3, and 2 and 3was calculated using the Pearson product-moment cor-
relation coefficient (r). Application of the Kolmogorov-
Smirnov test [18] confirmed that the difference between
the pairs of scans followed a Gaussian distribution. To
investigate the interscan reproducibility of three baseline
scans, we compared scans 1 and 2, 1 and 3, and 2 and 3
for LN volumes and SUVmean, SUVmax, SUVthreshold,
mSUVthreshold, and SUVfixed volume using Bland-Altman
analysis [19]. The mean difference, standard deviation of
the mean differences (SD), coefficient of repeatability
(CR), and limits of agreement (LoA) were calculated and
represented as Bland-Altman plots. The SD was calcu-
lated by squaring all the differences, adding them up,
dividing them by the number of measurements, and tak-
ing the square root. The LoA were calculated by adding
(upper limit) or subtracting (lower limit) the CR, defined
as CR = 1.96 × SD, from the mean difference. This ana-
lysis of data reproducibility was performed with the as-
sumption that the animal health status did not change
during the time the scans were obtained 5 to 21 days prior
to monkeypox virus inoculation. Unchanged animal health
status was confirmed by physical examination.
Bland-Altman analysis was subsequently used to inves-
tigate the agreement between five VOI metrics for peak
18F-FDG uptake in the LNs of survivors on day 10 after
inoculation. The differences obtained for each animal
were plotted against the mean differences of the respect-
ive pairs of VOI measures. For acceptable agreement,
the 95% LoA (±1.96 SD of the mean difference) should
include 95% of the difference between the methods of
measurement. Two-way repeated measures analysis of
variance (ANOVA) was employed to explore the differ-
ence between treated and untreated groups or surviving
and moribund groups in LN 18F-FDG uptake using SUVs
with five different VOI metrics. We used 18F-FDG uptake
value at different time points (days −1, −2, −3 pre- and
days +1 or +2 and +3 or +4 postinoculation with mon-
keypox virus) as within factor and treatment or disease
outcome as between factors, respectively. Post hoc com-
parisons were performed using Bonferroni test. GraphPad
Prism 6.01 (GraphPad Software Inc., La Jolla, CA, USA)
was used for all statistical analyses.
Results
Three baseline CT scans prior to monkeypox virus in-
oculation were used to investigate interscan repeatability
of analysis of LN volumes from the right axilla for appli-
cation in SUVmean computations. The mean LN volume
and SD averaged for all six subjects from pre-inoculation
scans 1, 2, and 3 were 0.43 ± 0.17, 0.42 ± 0.14, and 0.43 ±
0.14 cm3, respectively, as measured on CT images. The
correlation coefficient, r, of pairwise comparisons between
the LN volume determined on baseline scans 1 and 2, 1
and 3, and 2 and 3 was 0.94 (p = 0.006), 0.95 (p = 0.004),
Figure 2 Bland-Altman plots comparing the agreement between the LN volume measurements from baseline CT scans. Scans were
performed on three separate days prior to monkeypox virus inoculation. Differences between two pairwise measurements of LN volumes in each
animal (n = 6) (scans 1 and 2 (a), 1 and 3 (b), and 2 and 3 (c)) are plotted against mean volume of the two scans. Dashed lines show the limits
of agreement, and solid lines show the mean difference between LN volumes.
Table 1 Repeatability of 18F-FDG SUV measurements in














Scans 1 and 2 −0.40 ± 1.84 −4.01, 3.20 3.60
Scans 1 and 3 0.16 ± 1.74 −3.25, 3.57 3.41
Scans 2 and 3 0.57 ± 1.18 −1.75, 2.88 2.31
mSUVthreshold
Scans 1 and 2 −0.89 ± 1.42 −3.68, 1.90 2.79
Scans 1 and 3 −0.41 ± 0.92 −2.21, 1.39 1.80
Scans 2 and 3 0.22 ± 1.94 −3.59, 4.03 3.81
SUVthreshold
Scans 1 and 2 −0.28 ± 0.89 −2.02, 1.46 1.74
Scans 1 and 3 −0.21 ± 0.50 −1.19, 0.78 0.99
Scans 2 and 3 0.19 ± 1.26 −2.28, 2.65 2.47
SUVmean
Scans 1 and 2 0.004 ± 1.08 −2.12, 2.19 2.12
Scans 1 and 3 0.15 ± 0.72 −1.26, 1.56 1.41
Scans 2 and 3 0.12 ± 0.78 −1.41, 1.64 1.52
SUVmax
Scans 1 and 2 −1.61 ± 3.01 −7.52, 4.29 5.91
Scans 1 and 3 0.004 ± 1.82 −3.52, 3.53 3.53
Scans 2 and 3 1.65 ± 3.51 −5.23, 8.54 6.88
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tween the LN volume measurements on different days be-
fore inoculation was confirmed by Bland-Altman analysis
(Figure 2). The mean differences and SD of the LN vol-
ume from scans 1 and 2 (Figure 2a), 1 and 3 (Figure 2b),
and 2 and 3 (Figure 2c) were 0.022 ± 0.06, 0.003 ± 0.060,
and 0.018 ± 0.048 cm3, respectively. CRs of these scans
were 0.13, 0.12, and 0.09, respectively.
The range of blood glucose concentrations for all ani-
mals (n = 6) measured before each scanning session var-
ied between 60 and 72 mg/dL. No correlation was noted
between changes in 18F-FDG uptake over the course of
monkeypox virus infection and the variation in glucose
concentration measured before each scanning session on
different days before and after virus inoculation.
Mean SUV ± SDs for three baseline scans, 1.98 ±
0.74 (SUVmean), 6.25 ± 2.21 (SUVmax), 3.55 ± 0.90
(SUVthreshold), 3.36 ± 1.09 (mSUVthreshold), and 3.20 ±
1.25 (SUVfixed volume) in all the animals varied depending on
VOI metrics. To determine interscan variability, the mean
differences in SUVs from each of the three baseline PET
scans were calculated by Bland-Altman analysis. Although
all the differences for the SUVs were within ±1.96 SD, the
worst agreement for the baseline scans was with SUVmax as
shown by greater values for three outcome measures of
Bland-Altman analysis, the mean difference and SD, 95%
LoA, and CR (Table 1). Compared with mSUVthreshold and
SUVfixed volume, SUVmean and SUVthreshold had smaller SDs
on different scanning days as a result of larger volumes
used in these SUV computations.
Following inoculation of monkeypox virus, the charac-
terization of infection in NHPs and histological evalu-
ation of LN tissue during infection is described in
Additional file 1. One animal in the untreated group
survived the infection, while the remaining two subjects
became moribund on day 7 after inoculation.In examining VOI metrics, all five SUVs showed good
concurrence for the pattern of changes in LN metabolic
activity in survivors (animal numbers 1 to 3 [cidofovir-
treated], number 6 [untreated]) over the course of mon-
keypox virus infection (Figure 3). 18F-FDG uptake was
Figure 3 Impact of VOI definition on the SUVs of axillary LN during monkeypox virus infection. Animal numbers 1 to 3 ((a), (b), (c)) and
numbers 4 to 6 ((d), (e), (f)) represent those treated with cidofovir and those left untreated, respectively. Animal numbers 1 to 3 and number 6
survived the infection.
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through +3 days postinoculation (Additional files 2 and 3),
increased markedly after day +3 postinoculation, and
peaked on day +10 (Figure 3). Average SUVs ± SDs in all
surviving animals on day +10 postinoculation were 12.02 ±
2.00 (SUVmean), 24.48 ± 3.01 (SUVmax), 16.65 ± 2.14
(SUVthreshold), 17.69 ± 0.69 (mSUVthreshold), and 16.98 ±
1.84 (SUVfixed volume) (Figure 3a,b,c,f). Similar to the SUVs
obtained from LNs prior to inoculation, the values were
comparable among SUVfixed volume, mSUVthreshold, and
SUVthreshold but were always above SUVmean and less than
the SUVmax by 30% to 40%. In addition, SUVmean for each
of the animals were characterized by substantial SD as a re-
sult of great SUV variability of the voxels included in the
calculation, which led to coefficients of variation (CV)
for SUVmean between 40% and 60% on most scanning
days (Figure 4). In contrast, the CVs for SUVfixed volume,
mSUVthreshold, and SUVthreshold were rarely greater than
20%. These higher CV values were mostly observed on
the images from the baseline scans with a low rate of
LN metabolic activity that was comparable to surround-
ing tissue.
For the peak 18F-FDG uptake observed in survivors on
day +10 postinoculation, the best correspondence was
between SUVfixed volume and mSUVthreshold (Figure 5a).
The mean difference and SD between the two measure-
ments were (−0.71) ± 1.84. Similar agreement wasbetween mSUVthreshold and SUVthreshold with the bias of
(1.043) ± 1.71 (Figure 5b) and between SUVfixed volume
and SUVthreshold, but the SD was greater between the
latter two SUV methods (Figure 5c). The Bland-Altman
plot revealed poor agreement between SUVfixed volume
and SUVmax, mSUVthreshold and SUVmax, SUVfixed volume
and SUVmean, mSUVthreshold and SUVmean, and SUVmean
and SUVthreshold as shown by the mean difference between
any of the two pairs of 5 or greater or less than −5
(Figure 5d,e,f,g,h). Very poor agreement was found be-
tween SUVmax and SUVmean (Figure 5i) and between
SUVmax and SUVthreshold (Figure 5j); the bias and SD be-
tween the two measurements were (12.5 ± 1.2) and (7.8 ±
0.89), respectively.
PET images revealed an increase in 18F-FDG-PET up-
take by the LNs on day +3 or +4 postinoculation in ani-
mals that eventually became moribund compared with
surviving animals (Figure 6a and Additional file 3 show
CT/PET images of one representative animal from each
group). To explore whether the pattern of changes in a
LN metabolic activity can predict a disease outcome and
specify the effect of cidofovir treatment, we analyzed a
subset of the data up to day +7 postvirus inoculation by
two-way repeated measure ANOVA. Results of statistical
analysis indicate differences in the pattern of 18F-FDG-
PET uptake changes in moribund and surviving groups
at early time points postinoculation (up to day +3 or +4)
Figure 4 CV for SUVmean, SUVfixed volume, mSUVthreshold, and SUVthreshold calculated for each scanning session in each animal. Each
column of four sets of data shown by different shades of black and gray represent CVs for a single time point before (pre-inoculation days −20, −15,
and −5) and after (days +1 or +2, +3 or +4, +7 or +8, +10, +16, and +21) virus inoculation. On the x-axis, the infection progression is from the left to
the right (e.g., first three columns from the left in each data set represent the data from three sequential baseline scans prior inoculation). Animal
numbers 1 to 3 ((a), (b), (c)) and numbers 4 to 6 ((d), (e), (f)) represent those treated with cidofovir and those left untreated, respectively.
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significant interaction between moribund and surviving
groups, p = 0.006 and p = 0.0164, respectively, Figure 6b,c).
Other SUV methods did not distinguish between changes
in 18F-FDG-PET uptake in moribund and surviving groups
(Figure 6d,e,f). Bonferroni’s multiple comparison test speci-
fied a statistically significant increase in 18F-FDG uptake in
moribund group on days +3 or +4 postinoculation com-
pared with surviving group (adjusted p = 0.0037 and p =
0.0001, for mSUVthreshold and SUVfixed volume, respectively).
No statistically significant effects were found between
cidofovir-treated and untreated groups.
Discussion
In this paper, we compared the agreement between con-
ventional and modified VOI metrics to identify which
metric(s) provide(s) reproducible SUVs when monitoring
18F-FDG uptake in the LN over the course of monkey-
pox virus infection (Table 2). The interscan data repro-
ducibility for the LN volume in baseline scans ensures
consistency in defining the whole LN boundaries on CT
images and indicates the degree of reliability of VOI for
SUVmean calculation. Among five methods for the SUV
calculation, SUVmax demonstrates the worst agreement
between three baseline scans. These results confirm
findings from similar studies involving cancer patients[15,20]. Replicate scans performed within a short period
of time on the same patient using an identical technique
often produce poorer interstudy reproducibility for
SUVmax than for SUVs averaging greater volumes [15].
Taking into account the low baseline rate of LN meta-
bolic activity that was comparable to the background
rate in surrounding tissue and small LN size, the repeat-
ability of SUV measurement for the baseline scans in
our study is improved by increasing the volume in-
cluded in other VOI metrics.
Overall, the qualitative pattern of changes in LN 18F-
FDG uptake over the course of monkeypox virus infec-
tion is similar between SUVs with the five VOI metrics
evaluated in this study (Figure 3). However, SUVs vary
substantially depending on VOI definition. The SUVs ob-
tained with SUVthreshold, mSUVthreshold, and SUVfixed volume
VOI metrics are within similar ranges and always above
the range for the SUVmean and below the SUVmax.
SUVmax could be the most attractive method to use for
monitoring an immune response using multiple sequen-
tial PET scans because SUVmax is independent of the
observer and simple to apply, Table 2 [10,14,23]. Despite
these advantageous properties, the use of SUVmax is
greatly influenced by adverse effects of noise [21]. This
weakness of SUVmax in combination with a random
voxel location limit the ability of SUVmax not only to
Figure 5 Comparison of SUVs in LNs on day 10 postinoculation with monkeypox virus of survivors. Pairwise comparisons were performed
between SUVs with varied VOI metrics: (a) SUVfixed volume vs mSUVthreshold, (b) SUVfixed volume vs SUVthreshold, (c) mSUVthreshold vs SUVthreshold,
(d) SUVfixed volume vs SUVmax, (e) mSUVthreshold vs SUVmax, (f) SUVfixed volume vs SUVmean, (g) mSUVthreshold vs SUVmean, (h) SUVmax vs SUVmean,
(i) SUVmax vs SUVthreshold, and (j) SUVmean vs SUVthreshold in four surviving animals. Dashed lines show the limits of agreement, and solid lines
show the mean difference between LN volumes.
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(baseline scans) but also to quantify reliably real changes
in the LN metabolic activity during viral infection.
The major drawback of SUVmean is the time consum-
ing process of manual LN delineation on each of theslices in the 3D CT images set. Similar to small tumors,
LN PET images are difficult to align perfectly with CT
images that often have poor soft tissue contrast. As a re-
sult, individual SUVmean during infection could be under-
estimated by inclusion of voxels with lower metabolic
Figure 6 SUVs in the axillary LN during monkeypox virus infection in surviving and moribund groups. SUVs were assessed by five
methods for VOI metrics, (a) SUVfixed volume, (b) mSUVthreshold, (c) SUVmax, (d) SUVmean, and (e) SUVthreshold, in four surviving and two
moribund animals.
Table 2 Advantages and drawbacks of SUV methods with different VOI metrics used in the current study
[5-8,11-15,21,22]
SUV metrics Current use in
clinical settings
Major drawbacks or advantages References Statistically significant
effects in current study
SUVmean + • PVE at the edges of target region [5,6,11-14,21] No
• Time consuming to outline target region
• Inclusion of nontarget tissue
SUVmax + • Susceptible to noise [8,21,22] No
• Random voxel location
• Independent of observer
• Easy to apply
SUVthreshold + • Inclusion of nontarget tissue [7,14,15] No
• Less sensitive to noise
• Easy to apply
• More reproducible than SUVmean
SUVfixed volume (placement adjusted
in current study)
+ • Less sensitive to noise than SUVmax [7,8] Yes
• Limits PVE at edges of target region
• Relatively similar location of voxels between
scans and between animals
mSUVthreshold − • Less sensitive to noise than SUVmax Yes
• Relatively easy to apply
• Limits PVE at edges of target region
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the LN boundaries on CT images (Figure 6e). Partial-
volume effect (PVE) at the edges is another factor contrib-
uting to underestimation of the values with SUVmean
[5,22,24]. Consequently, SUVmean is characterized by sub-
stantial data variability within the VOI as shown by CVs
generally greater than 40% (Figure 4). Similarly, the dy-
namic range of the SUVmean is the widest compared with
other methods (see Additional file 4).
The use of threshold-based methodology is attractive
since the LN delineation on 18FDG-PET images is easy
to perform, and this method provides more reproducible
measures than SUVmax and SUVmean [7,14]. A disadvan-
tage of the threshold technique is that the threshold is
chosen rather arbitrarily, and only metabolically active
tissue can be used for its application. Setting a threshold
in normal LNs is more difficult compared with active
LNs as metabolic activity in normal LNs appears to be
similar to that in surrounding tissue (Additional files 2
and 5). At early time points postinoculation, the 18F-FDG
uptake in surrounding tissue is often higher than that in
the LN leading to an inclusion of the majority of the
voxels outside the LN edges in SUVthreshold computation
(Figure 1b, Additional file 2). Similarly, this method
proved to be unsuitable to monitor tumor response after
treatment since nontumor tissue is very often also in-
cluded in the VOI [14]. To eliminate inclusion of voxels
from surrounding tissue with high 18F-FDG uptake, we
limited the volume for thresholding by placing a spherical
VOI in the middle of a LN. This modification in the pro-
cedure improves data variability as shown in Figure 4.
SUVfixed volume focuses on the metabolic response
within a restricted location of the LN taking into ac-
count changes in LN shape and size in rhesus macaques
over the course of infection. This VOI metric includes
selected voxels from a slice in the middle of a LN, where
metabolic activity is usually higher compared with the
LN edges, and covers relatively similar locations standard-
ized between different animals and scanning sessions.
Thus, by avoiding the edges of the LN, we minimize the
PVE associated with SUVmean metrics, and, similar to
mSUVthreshold, SUVfixed volume excludes voxels from tissues
surrounding the LN. SUVfixed volume and mSUVthreshold
demonstrate the best agreement among other SUVs
between the values for the peak response in survivors
(Figure 6). These two methods are associated with similar
statistically significant increases in 18F-FDG uptake in
moribund group at day +3 or +4 postinoculation of mon-
keypox virus compared with surviving group.
There are several limitations in our present work. Al-
though the size of the LNs assessed in this study was
within the scanner resolution, PVE correction was not
applied. The best method to correct for PVE has yet to
be determined as such correction by itself can produce abias in measured uptake. Further studies are needed to
explore the relevance of PVE correction in the context
of PET imaging of the LN immune response.
The aim of this preliminary study in a limited number
of subjects is to compare different methods for deter-
mining the SUV and choose the method(s) with the best
agreement to be applied in future characterization of a
LN response to viral infection. The low number of sub-
jects is not sufficient to demonstrate whether other more
subtle effects (e.g., treatment effects), besides differentiat-
ing between disease outcomes, can be demonstrated from
application of the SUVfixed volume and mSUVthreshold met-
rics. The current data do not provide any explanation for
the lack of difference between treated and untreated survi-
vors in terms of 18FDG uptake by the LN. Perhaps the lack
of difference may be related to the sensitivity of the
methods or the contribution of other processes not associ-
ated with metabolic activity.
Also, we cannot rule out the possibility that differences
at day +3 or +4 postvirus inoculation could be explained
by a suboptimal study design. To ensure consistency in
viral stock properties (e.g., titers, number of passages)
and in inoculation procedures, all NHPs were infected
on the same day (day 0). However, imaging of treated and
untreated groups was staggered over 2 days (e.g., days +3
or +4 postinoculation) to accommodate PET scanner
availability and duration of pre- and postscan procedures
in sick animals in a biosafety level 3 environment.
Despite these limitations, a similar pattern of changes in
18F-FDG uptake in the LNs is observed in treated and un-
treated surviving NHPs irrespective of timing of scans but
is not observed between untreated surviving and mori-
bund animals scanned on the same day. Future studies
with larger group of animals and improved study design
will be able to clarify this issue. In addition, an intra- and
interrater reliability evaluation of LN volume and SUVs
should be considered in further studies. Another point for
potential criticism for the current study could be the lack
of ground truth for LN 18F-FDG uptake.
Conclusions
We confirmed results of previous studies that quantifica-
tion of changes in 18F-FDG-PET is highly sensitive to
the method applied for PET image analysis. Evaluation
of multiple approaches is necessary in choosing appro-
priate method(s) to monitor changes in LN metabolic
activity during progression of infection. Results of our
study indicate that SUVfixed volume and mSUVthreshold are
more reproducible than the other methods and provide
the best agreement for SUV calculation. Both methods
reduce the impact of noise, minimize the PVE, limit in-
clusion of background signals, and substantially decrease
the SD of the mean SUVs. The improved precision of
the SUV estimates with the proposed methods results in
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surviving groups at an early stage of monkeypox virus
infection that is not detected with the other three methods.
Therefore, SUVfixed volume and mSUVthreshold are the pre-
ferred approaches rather than SUVmax, SUVthreshold, or
SUVmean for quantitative analysis of LN immune response
over the course of monkeypox virus infection using
18F-FDG-PET. Consequently, these preferred methods
may provide better tools for establishing 18F-FDG up-
take by the LNs as a marker of functional response at an
early stage of monkeypox virus infection.
Additional files
Additional file 1: The macaque preparation, clinical course, and
histological analyses following intravenous monkeypox virus
challenge.
Additional file 2: Elevated 18F-FDG uptake in tissue surrounding
the LN on day 3 after virus inoculation. Maximum intensity projection
(MIP) movie and representative 18F-FDG-PET images fused with CT
images of an axillary LN in sagittal view acquired -5 days before and day +3
and 10 after virus inoculation. High 18F-FDG uptake is observed in tissue
surrounding the LN on day +3 after virus inoculation.
Additional file 3: Elevated 18F-FDG uptake in axillary LN of an
animal that eventually became moribund. MIP movie and
representative 18F-FDG-PET images fused with CT images of an axillary LN
in sagittal view acquired before and on day 3 after monkey virus
inoculation showing elevated 18F-FDG uptake in axillary LN of an animal
that eventually became moribund.
Additional file 4: Dynamic range for SUVmean, SUVfixed volume,
mSUVthreshold, and SUVthreshold assessed before and after virus
inoculation. Dynamic range was calculated for single time points before
(pre-inoculation days −20, −15, and −5) and after (days +1 or +2, +3 or +4, +7
or +8, +10, +16, and +21) virus inoculation in each animal. On the x-axis, the
infection progression is from the left to the right. Data for voxels with
negative values are not included.
Additional file 5: Enlarged fused CT/PET images of axillary LN from
representative moribund and surviving animals. On day -5 pre- (top
row) and day +3 or +4 postvirus (bottom row) inoculation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JD and RFJ were involved in the study design, implementation, data
collection, and manuscript preparation. RCR participated in the design of the
study, data analysis, and manuscript preparation. JS and CZL were involved
in the study implementation and data analysis. JEB and PBJ were involved in
study design. SC was involved in development of methods for image
quantitation and statistical analysis and wrote the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We thank Jennifer Hufton from the imaging team, Russell Byrum from the
NIAID Comparative Medicine Branch, and Comparative Medicine
veterinarians for successful implementation of PET-CT scanning protocols in
the biosafety level 3 suite. In addition, we acknowledge Shen Kui for help
with statistical analysis. We thank Laura Bollinger and Jiro Wada for outstanding
assistance in technical writing and figure preparation of this manuscript on
behalf of the Battelle Memorial Institute. This work was supported by the
Division of Intramural Research of the National Institute of Allergy and Infectious
Diseases (NIAID), Integrated Research Facility (NIAID, Division of Clinical
Research), and Battelle Memorial Institute’s prime contract with NIAID (Contract
number HHS N272200700016I).Author details
1Division of Clinical Research, Integrated Research Facility, National Institute
of Allergy and Infectious Diseases, National Institutes of Health, 8200
Research Plaza, Frederick, MD 21702, USA. 2Center for Infectious Disease
Imaging, Radiology and Imaging Sciences, Clinical Center, National Institutes
of Health, 10 Center Drive, Bethesda, MD 20892, USA. 3Division of Intramural
Research, Emerging Viral Pathogens Section, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 8200 Research Plaza,
Frederick, MD 21702, USA.
Received: 22 May 2014 Accepted: 4 September 2014
References
1. Dyall J, Johnson RF, Chen DY, Huzella L, Ragland DR, Mollura DJ, Byrum R,
Reba RC, Jennings G, Jahrling PB, Blaney JE, Paragas J: Evaluation of
monkeypox disease progression by molecular imaging. J Infect Dis 2011,
204:1902–1911.
2. Johnson RF, Dyall J, Ragland DR, Huzella L, Byrum R, Jett C, St Claire M,
Smith AL, Paragas J, Blaney JE, Jahrling PB: Comparative analysis of
monkeypox virus infection of cynomolgus macaques by the intravenous
or intrabronchial inoculation route. J Virol 2011, 85:2112–2125.
3. Huang SC: Anatomy of SUV. Standardized uptake value. Nucl Med Biol
2000, 27:643–646.
4. Thie JA: Understanding the standardized uptake value, its methods, and
implications for usage. J Nucl Med 2004, 45:1431–1434.
5. Adams MC, Turkington TG, Wilson JM, Wong TZ: A systematic review of
the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol
2010, 195:310–320.
6. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA: Effects of noise, image
resolution, and ROI definition on the accuracy of standard uptake
values: a simulation study. J Nucl Med 2004, 45:1519–1527.
7. Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA:
Effects of ROI definition and reconstruction method on quantitative
outcome and applicability in a response monitoring trial. Eur J Nucl Med
Mol Imaging 2005, 32:294–301.
8. Vanderhoek M, Perlman SB, Jeraj R: Impact of the definition of peak
standardized uptake value on quantification of treatment response.
J Nucl Med 2012, 53:4–11.
9. Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA,
Lebesque JV: Standardised FDG uptake: a prognostic factor for inoperable
non-small cell lung cancer. Eur J Cancer 2005, 41:1533–1541.
10. Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J,
Weber WA: Treatment monitoring by 18F-FDG PET/CT in patients with
sarcomas: interobserver variability of quantitative parameters in
treatment-induced changes in histopathologically responding and
nonresponding tumors. J Nucl Med 2008, 49:1038–1046.
11. Dimitrakopoulou-Strauss A, Hoffmann M, Bergner R, Uppenkamp M,
Eisenhut M, Pan L, Haberkorn U, Strauss LG: Prediction of short-term
survival in patients with advanced nonsmall cell lung cancer following
chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron
emission tomography: a feasibility study. Mol Imaging Biol 2007, 9:308–317.
12. Lucignani G: SUV and segmentation: pressing challenges in tumour
assessment and treatment. Eur J Nucl Med Mol Imaging 2009, 36:715–720.
13. Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG,
Brizel DM: Analysis of pretreatment FDG-PET SUV parameters in
head-and-neck cancer: tumor SUVmean has superior prognostic value.
Int J Radiat Oncol Biol Phys 2012, 82:548–553.
14. Vriens D, De Geus-Oei LF, Van Laarhoven HW, Van Der Heijden HF,
Krabbe PF, Visser EP, Oyen WJ: Comparison of two region of interest
definition methods for metabolic response evaluation with
[(1) (8)F]FDG-PET. Q J Nucl Med Mol Imaging 2010, 54:677–688.
15. Burger IA, Huser DM, Burger C, von Schulthess GK, Buck A: Repeatability of
FDG quantification in tumor imaging: averaged SUVs are superior to
SUVmax. Nucl Med Biol 2012, 39:666–670.
16. Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, Laforest R:
Performance evaluation of the microPET focus: a third-generation microPET
scanner dedicated to animal imaging. J Nucl Med 2005, 46:455–463.
17. Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH: High-resolution
3D Bayesian image reconstruction using the microPET small-animal
scanner. Phys Med Biol 1998, 43:1001–1013.
Chefer et al. EJNMMI Research 2014, 4:49 Page 12 of 12
http://www.ejnmmires.com/content/4/1/4918. Press WH: Numerical Recipes in C: The Art of Scientific Computing. 2nd
edition. Cambridge, UK: Cambridge University Press; 1992.
19. Bland JM, Altman DG: Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986, 1:307–310.
20. Nahmias C, Wahl LM: Reproducibility of standardized uptake value
measurements determined by 18F-FDG PET in malignant tumors. J Nucl
Med 2008, 49:1804–1808.
21. Lodge MA, Chaudhry MA, Wahl RL: Noise considerations for PET
quantification using maximum and peak standardized uptake value.
J Nucl Med 2012, 53:1041–1047.
22. Soret M, Bacharach SL, Buvat I: Partial-volume effect in PET tumor
imaging. J Nucl Med 2007, 48:932–945.
23. Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y:
Interobserver variability among measurements of the maximum and
mean standardized uptake values on (18)F-FDG PET/CT and
measurements of tumor size on diagnostic CT in patients with
pulmonary tumors. Acta Radiol 2010, 51:782–788.
24. Graham M: Quantification of Radiotracer Uptake into Tissue. In Molecular
Imaging: Principles and Practice. Edited by Weissleder R, Ross BD, Rehemtulla A,
Gambhir SS, Shelton CT. USA: People’s Medical Pub. House; 2010:1258–1270.
doi:10.1186/s13550-014-0049-z
Cite this article as: Chefer et al.: The effect of volume of interest
definition on quantification of lymph node immune response to a
monkeypox virus infection assessed by 18F-FDG-PET. EJNMMI Research
2014 4:49.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
